Participants 90 153 4
interferon alpha monotherapy relapsers with chronic hepatitis C
Participants 712 769 3
interferon monotherapy relapsers with chronic hepatitis C
Participants 779 842 4
Interferon alpha monotherapy relapsers with chronic hepatitis C
Participants 1181 1247 4
Only patients with negative HCV RNA at week 10 continued treatment
Participants 1308 1452 10
Thirty-seven patients were enrolled, 19 (6 females, median age 43) in the 24 week and 18 (5 females, median age 40) in the 48 week treatment arm
Participants 1841 1948 3
Three patients discontinued treatment early (two due to moderate adverse events, one due to non-compliance)
